NOTIFICATION OF THE REMOVAL FROM LISTING
AND REGISTRATION OF THE STATED SECURITIES

The null hereby notifies the SEC of its intention
to remove the entire class of the stated securities
from listing and registration on the Exchange at the
opening of business on February 25, 2013, pursuant
o the provisions of Rule 12d2-2 (a).

[ X ] 17 CFR 240.12d2-2(a)(3) That on February 8, 2013
the instruments representing the securities comprising
the entire class of this security came to evidence, by
operation of law or otherwise, other securities in
substitution therefore and represent no other right
except, if such be the fact, the right to receive an
immediate cash payment.

The merger between YM BioSciences Inc.
and 3268218 Nova Scotia Limited, a wholly-owned
subsidiary of Gilead Sciences, Inc. became effective on
February 8, 2013. Each share of Common Stock of YM
BioSciences Inc. was converted into $2.95 in cash per share.

The Exchange also notifies the Securities and
Exchange Commission that as a result of the above
indicated conditions this security was suspended from
trading on February 11, 2013.